WallStreetZenWallStreetZen

NASDAQ: CTSO
Cytosorbents Corp Stock Ownership - Who owns Cytosorbents?

Insider buying vs selling

Have Cytosorbents Corp insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Michael G. BatorDirector2023-12-1337,594$1.33
$50.00kBuy
Kathleen P. BlochChief Financial Officer2023-12-1337,594$1.33
$50.00kBuy
Vincent CapponiPresident COO2023-12-1318,797$1.33
$25.00kBuy
Phillip P. ChanChief Executive Officer2023-12-1375,188$1.33
$100.00kBuy
Efthymios DeliargyrisChief Medical Officer2023-12-1322,557$1.33
$30.00kBuy
Edward Raymond JonesDirector2023-12-137,519$1.33
$10.00kBuy
Jiny KimDirector2023-12-137,519$1.33
$10.00kBuy
Alan D. SobelDirector2023-12-1322,557$1.33
$30.00kBuy

1 of 1

CTSO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CTSO insiders and whales buy or sell their stock.

CTSO Shareholders

What type of owners hold Cytosorbents Corp stock?
Institutional
Insider
Retail
NameHoldSharesValueType
David Lamadrid14.40%7,837,500$7.84MInsider
Guillermina Vega Montiel9.18%4,993,984$4.99MInsider
Margie Chassman8.81%4,795,000$4.80MInsider
Robert Shipley5.46%2,972,819$2.97MInsider
Avenir Corp5.46%2,970,262$2.97MInstitution
Skylands Capital LLC5.22%2,840,778$2.84MInstitution
Granahan Investment Management LLC4.89%2,663,811$2.66MInstitution
Njtc Investment Fund LP4.69%2,554,999$2.55MInsider
Vanguard Group Inc3.58%1,949,551$1.95MInstitution
Neuberger Berman Group LLC2.82%1,536,514$1.54MInstitution

1 of 3

CTSO vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CTSO30.50%50.81%Net Buying
DHAI2.68%46.79%
NVNO18.68%63.84%Net Buying
COCH5.93%73.51%Net BuyingNet Buying
LUCD3.69%64.85%Net Buying

Cytosorbents Stock Ownership FAQ

Who owns Cytosorbents?

Cytosorbents (NASDAQ: CTSO) is owned by 30.50% institutional shareholders, 50.81% Cytosorbents insiders, and 18.69% retail investors. David Lamadrid is the largest individual Cytosorbents shareholder, owning 7.84M shares representing 14.40% of the company. David Lamadrid's Cytosorbents shares are currently valued at $7.84M.

If you're new to stock investing, here's how to buy Cytosorbents stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.